Creatio is the leading Academic Center for the Production and Validation of Advanced Therapies of State associated with the University of Barcelona and technological developer with TECNIO accreditation, that promotes innovation and translation.
Creatio perform all the activities and processes following high quality standards under compliance of ISO 9001:2015, GLP (Good Laboratory Practices) and GMP (Good Manufacturing Practices).
With long-standing experience, Creatio provides support and solutions that cover all the development process of a healthcare product to increase the efficiency of the healthcare system and improve the quality of life of society.
With a forceful focus on translation, we use our expertise in cell and molecular biology; in preclinical studies and clinical production; and in regulatory aspects to develop effective cutting-edge drugs and treatments for patients. Our experience in cell, gene therapy and tissue engineering aims to bridge the gap between research and clinical applications.
17 December, 2024
Nowadays, diseases such as cancer, inflammatory diseases, autoimmune diseases and neurodegenerative diseases are a challenge that medicine must face Currently, they have no cure or conventional treatments can only…
24 October, 2024
When a neuron ages, it loses synaptic connections with other neurons, it is less able to transmit nerve impulses, and its metabolism is also altered This process of neuronal ageing — inevitable with the passing of…
16 October, 2024
On Wednesday, October 2, 2024, Maria Camanyes and Natalie Chaves, researchers at Creatio, a center for the production and validation of advanced therapies at the University of Barcelona, went to the Ferran…
2 October, 2024
We have started our return from summer break with a lot of energy Creatio attended the tenth edition of the Farmaforum within the Biotechforum during 24th and 25th September 2024, held at IFEMA (Madrid) It is an…
Creatio has been the first center to produce lentiviruses for CAR-T (Chimeric Antigen Receptor-T) cells treatment in clinical trials in Spain This new breed of treatment is currently revolutionizing the therapeutic…
CHDI Foundation is a privately-funded, not-for-profit biomedical research organization devoted to a single disease – Huntington’s disease Its mission is to develop drugs that will slow the progression of…
The first accreditation from the Spanish Agency of Medicine and Sanitary Products (AEMPS) to Creatio Production and Validation Center of Advanced Therapies in the University of Barcelona: permission is granted to…
